Patricia Antero, DPM
Foot & Ankle Surgery · Tuscaloosa, ALNPI 1053392175
Payments from drug & device makers
What this record shows
This record is dominated by other: $30,800 of the $35,330 with a category attached, or 87.2%. Convatec Inc. accounts for 87.2% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2024 at $31,916 and has fallen 99.3% since, to $239 in 2025.
Across 120 payments — averaging $294.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$31K
- Prime Surgical, LLC$2K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$554
- Amgen$462
- Arthrex$451
- Melinta Therapeutics, LLC$213
- plus $1K from 21 others
What the payments were for
- Travel & lodging$1,2474%
- Food & beverage$2,6287%
- Education$6552%
- Other$30,80087%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 10 | $30,800 |
| Prime Surgical, LLC | 4 | $1,622 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 31 | $554 |
| Amgen(2 entities) | 13 | $462 |
| Arthrex | 2 | $451 |
| Melinta Therapeutics, LLC | 10 | $213 |
| Paratek Pharmaceuticals, Inc. | 9 | $145 |
| Vaporox, Inc. | 1 | $139 |
| Hydrofera LLC | 1 | $132 |
| Merck | 10 | $114 |
| Organogenesis Inc. | 2 | $112 |
| Stryker | 2 | $107 |
| GRT US Holding, Inc. | 6 | $98 |
| Paragon 28, Inc. | 1 | $73 |
| Zyla Life Sciences, Inc. | 3 | $54 |
| Medtronic | 2 | $32 |
| Orthofix Medical, Inc. | 2 | $31 |
| AbbVie(2 entities) | 2 | $27 |
| Smith+Nephew | 1 | $22 |
| Averitas Pharma Inc. | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $22 |
| Baudax Bio Inc. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $18 |
| Bioventus LLC | 1 | $15 |
| Abbott | 1 | $14 |
| Triad Life Sciences Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$30,800
- KRYSTEXXA$205
- VHT-200 Wound Treatment System$139
- HYDROFERA BLUE$132
- JUBLIA$103
How this compares
$35,330 in reported general payments places this provider in the 85th percentile of 40 foot & ankle surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 12 | $11,821 |
| Halobetasol Propionate | 13 | $2,321 |
| Clobetasol Propionate | 15 | $2,163 |
| Ciclopirox | 31 | $1,961 |
| Mupirocin | 178 | $1,550 |
| Alclometasone Dipropionate | 12 | $1,482 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 38 | $824 |
| Clindamycin Phosphate | 11 | $748 |
| Diclofenac Sodium | 32 | $629 |
| Gabapentin | 26 | $533 |
| Ketoconazole | 21 | $382 |
| Ciprofloxacin Hcl | 23 | $366 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 28 | $278 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 74 | $165 |
| Cephalexin | 20 | $124 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $554 | $11,82112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 40 foot & ankle surgery providers in Alabama.
Other foot & ankle surgery in Tuscaloosa
- Robert HopeTuscaloosa$2K
- Norman WaldropBirmingham$3.6M
- Justin DaigreDecatur$372K
- John KirchnerHoover$84K
- Jefferson SabatiniHuntsville$56K
- Matthew DeorioHuntsville$49K
- Ashish ShahBirmingham$28K
- Alfred RicciMontgomery$25K
- Swapnil SinghBirmingham$14K
- Derek KlavasMobile$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.